EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Potential of Rose Hip-Derived Nanoparticles for Psoriatic Skin Inflammation

Masahiro Hashimoto, Shoko Itakura iD, Kosuke Kusamori, Katsuhiko Yajima, Shota Mitsuhashi, Shinichiro Hayashi, Hiroaki Todo, Makiya Nishikawa iD

ACS Biomaterials Science & Engineering · 2025

DOI: 10.1021/acsbiomaterials.5c00826 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2025. Verfasst von Masahiro Hashimoto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1 Niijuku, Katsushika, Tokyo 125-8585, Japan. Hauptthemen laut MEDLINE: Psoriasis, Nanoparticles, Rosa. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology, Cosmetology Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a chronic skin disease characterized by hyperproliferation of keratinocytes and excessive inflammation. Plant-derived nanoparticles (pdNPs) are promising agents for treating inflammatory skin diseases. In this study, we examined the characteristics and functions of rose hip-derived nanoparticles (RNPs) rich in various bioactive compounds. RNPs were isolated from rose hips using sucrose ultracentrifugation and characterized using NanoSight and transmission electron microscopy. Cellular uptake by HaCaT human keratinocytes was analyzed using flow cytometry and confocal microscopy. Uptake mechanisms were investigated using siRNA knockdown. Proliferation, apoptosis, and cytokine expression were evaluated in a HaCaT psoriasis model. Antioxidant activity was assessed by measuring reactive oxygen species (ROS) levels in stimulated HaCaT and RAW264.7 mouse macrophage-like cells. The in vivo efficacy was evaluated in a mouse model of psoriasis via intradermal injection of RNPs. The RNPs obtained via ultracentrifugation exhibited a vesicular structure of approximately 100 nm in diameter. They were efficiently taken up by HaCaT cells and inhibited excessive inflammation-induced proliferation. RNPs reduced the mRNA levels of the inflammatory cytokines, interleukin-1β and interferon-γ. Additionally, RNPs were efficiently internalized by mouse macrophage-like RAW264.7 cells, decreasing the intracellular reactive oxygen species levels. The intradermal injection of RNPs effectively suppressed epidermal hyperproliferation and macrophage infiltration in an imiquimod-induced psoriasis mouse model. Collectively, these results suggest that RNPs can be used to treat psoriasis by regulating oxidative stress and inhibiting epidermal hyperproliferation. RNPs, which exerted potent effects on epidermal cells, target key pathological mechanisms such as oxidative stress and immune-driven keratinocyte proliferation. Therefore, they are promising natural therapeutic agents for psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisNanoparticlesRosaAnimalsHumansMiceRAW 264.7 CellsKeratinocytesCell ProliferationReactive Oxygen SpeciesHaCaT CellsInflammationImiquimodCytokinesAntioxidantsDisease Models, Animal

Stichwörter der Autor:innen

extracellular vesiclesintradermal injectionplant-derived nanoparticlepsoriasisrose hipskin disease

Substanzen

Reactive Oxygen SpeciesImiquimodCytokinesAntioxidants

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1 Niijuku, Katsushika, Tokyo 125-8585, Japan.
  • Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan.
  • Green Flask Laboratory, 1-25-1 Jiyugaoka, Meguro-ku, Tokyo 152-0035, Japan.

ORCID-Profile: Shoko Itakura, Makiya Nishikawa

Förderung

  • Japan Society for the Promotion of Science
  • Ministry of Education, Culture, Sports, Science and Technology
  • Cosmetology Research Foundation

Zitieren

APA

Hashimoto, M., Itakura, S., Kusamori, K., Yajima, K., Mitsuhashi, S., Hayashi, S., Todo, H., & Nishikawa, M. (2025). Therapeutic Potential of Rose Hip-Derived Nanoparticles for Psoriatic Skin Inflammation. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c00826

Vancouver

Hashimoto M, Itakura S, Kusamori K, Yajima K, Mitsuhashi S, Hayashi S, et al. Therapeutic Potential of Rose Hip-Derived Nanoparticles for Psoriatic Skin Inflammation. ACS Biomaterials Science & Engineering. 2025. doi:10.1021/acsbiomaterials.5c00826

BibTeX
@article{Hashimoto2025,
  author = {Hashimoto, Masahiro and Itakura, Shoko and Kusamori, Kosuke and Yajima, Katsuhiko and Mitsuhashi, Shota and Hayashi, Shinichiro and Todo, Hiroaki and Nishikawa, Makiya},
  title = {Therapeutic Potential of Rose Hip-Derived Nanoparticles for Psoriatic Skin Inflammation},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2025},
  doi = {10.1021/acsbiomaterials.5c00826}
}
Kostenlos starten →